Variant report
Variant | esv2759281 |
---|---|
Chromosome Location | chr4:125637940-125649621 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:84)
- CpG islands (count:61)
- Chromatin interactive region (count:15)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr4:125645349-125645375 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr4:125640129-125640446 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr4:125640102-125640475 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr4:125641790-125641917 | K562 | blood: | n/a | chr4:125641864-125641881 chr4:125641865-125641876 chr4:125641865-125641878 |
5 | CEBPB | chr4:125640145-125640329 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr4:125640135-125640372 | HepG2 | liver: | n/a | n/a |
7 | CEBPB | chr4:125640060-125640497 | HCT-116 | colon: | n/a | n/a |
8 | CTCF | chr4:125640040-125640190 | GM12878 | blood: | n/a | n/a |
9 | CTCF | chr4:125639961-125640332 | K562 | blood: | n/a | n/a |
10 | CTCF | chr4:125640101-125640243 | HepG2 | liver: | n/a | n/a |
11 | CTCF | chr4:125640040-125640190 | AG04449 | skin: | n/a | n/a |
12 | CTCF | chr4:125640040-125640190 | GM12871 | blood: | n/a | n/a |
13 | CTCF | chr4:125640100-125640250 | HPAF | blood vessel: | n/a | n/a |
14 | CTCF | chr4:125640260-125640410 | GM12866 | blood: | n/a | n/a |
15 | CTCF | chr4:125640080-125640230 | GM12867 | blood: | n/a | n/a |
16 | CTCF | chr4:125640166-125640177 | GM19240 | blood: | n/a | n/a |
17 | CTCF | chr4:125640100-125640250 | MCF-7 | breast: | n/a | n/a |
18 | CTCF | chr4:125640160-125640310 | GM12872 | blood: | n/a | n/a |
19 | CTCF | chr4:125640160-125640310 | HepG2 | liver: | n/a | n/a |
20 | CTCF | chr4:125640100-125640250 | Caco-2 | colon: | n/a | n/a |
21 | CTCF | chr4:125640040-125640190 | AG04450 | lung: | n/a | n/a |
22 | CTCF | chr4:125640154-125640181 | K562 | blood: | n/a | n/a |
23 | CTCF | chr4:125640020-125640170 | GM12874 | blood: | n/a | n/a |
24 | CTCF | chr4:125640260-125640410 | GM06990 | blood: | n/a | n/a |
25 | CTCF | chr4:125640160-125640310 | HMF | breast: | n/a | n/a |
26 | CTCF | chr4:125640106-125640219 | A549 | lung: | n/a | n/a |
27 | CTCF | chr4:125640040-125640190 | HMF | breast: | n/a | n/a |
28 | CTCF | chr4:125640060-125640210 | GM12866 | blood: | n/a | n/a |
29 | CTCF | chr4:125640040-125640190 | GM12873 | blood: | n/a | n/a |
30 | CTCF | chr4:125640080-125640230 | GM12872 | blood: | n/a | n/a |
31 | CTCF | chr4:125640180-125640330 | GM12873 | blood: | n/a | n/a |
32 | CTCF | chr4:125640080-125640230 | HCT-116 | colon: | n/a | n/a |
33 | CTCF | chr4:125640060-125640210 | GM12871 | blood: | n/a | n/a |
34 | CTCF | chr4:125639992-125640362 | K562 | blood: | n/a | n/a |
35 | CTCF | chr4:125640040-125640190 | GM12865 | blood: | n/a | n/a |
36 | CTCF | chr4:125640140-125640290 | GM12875 | blood: | n/a | n/a |
37 | CTCF | chr4:125640160-125640310 | K562 | blood: | n/a | n/a |
38 | CTCF | chr4:125640280-125640430 | A549 | lung: | n/a | n/a |
39 | CTCF | chr4:125640080-125640230 | GM12868 | blood: | n/a | n/a |
40 | CTCF | chr4:125640080-125640230 | GM12873 | blood: | n/a | n/a |
41 | CTCF | chr4:125640080-125640230 | GM12864 | blood: | n/a | n/a |
42 | CTCF | chr4:125640148-125640190 | H1-hESC | embryonic stem cell: | n/a | n/a |
43 | CTCF | chr4:125640080-125640230 | GM12869 | blood: | n/a | n/a |
44 | CTCF | chr4:125640040-125640190 | GM12864 | blood: | n/a | n/a |
45 | CTCF | chr4:125640069-125640297 | K562 | blood: | n/a | n/a |
46 | CTCF | chr4:125640180-125640330 | HepG2 | liver: | n/a | n/a |
47 | CTCF | chr4:125640075-125640226 | HepG2 | liver: | n/a | n/a |
48 | E2F4 | chr4:125644776-125644916 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | FOS | chr4:125647505-125647913 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | FOS | chr4:125646024-125646293 | MCF10A-Er-Src | breast: | n/a | chr4:125646155-125646165 chr4:125646155-125646165 chr4:125646152-125646163 chr4:125646155-125646165 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:125638274-125638324 | K562 | blood: | n/a |
2 | chr4:125638274-125638324 | AG04450 | lung: | fetal |
3 | chr4:125638274-125638324 | AG10803 | skin: | n/a |
4 | chr4:125638274-125638324 | GM12892 | blood: | n/a |
5 | chr4:125638274-125638324 | HRE | kidney: | n/a |
6 | chr4:125638274-125638324 | HCT-116 | colon: | n/a |
7 | chr4:125638274-125638324 | LNCaP | prostate: | n/a |
8 | chr4:125638274-125638324 | HNPCEpiC | eye: | n/a |
9 | chr4:125638274-125638324 | HEEpiC | esophagus: | n/a |
10 | chr4:125638274-125638324 | NHDF-neo | bronchial: | n/a |
11 | chr4:125638274-125638324 | HMEC | breast: | n/a |
12 | chr4:125638274-125638324 | NH-A | brain: | n/a |
13 | chr4:125638274-125638324 | HUVEC | blood vessel: | n/a |
14 | chr4:125638274-125638324 | CMK | blood: | n/a |
15 | chr4:125638274-125638324 | Caco-2 | colon: | n/a |
16 | chr4:125638274-125638324 | PANC-1 | pancreas: | n/a |
17 | chr4:125638274-125638324 | GM19239 | blood: | n/a |
18 | chr4:125638274-125638324 | GM12878 | blood: | n/a |
19 | chr4:125638274-125638324 | ECC-1 | luminal epithelium: | n/a |
20 | chr4:125638274-125638324 | SK-N-SH_RA | brain: | n/a |
21 | chr4:125638274-125638324 | AG09319 | gingival: | n/a |
22 | chr4:125638274-125638324 | ovcar-3 | ovarian: | n/a |
23 | chr4:125638274-125638324 | MCF10A-Er-Src | breast: | n/a |
24 | chr4:125638274-125638324 | U87 | brain: | n/a |
25 | chr4:125638274-125638324 | PrEC | prostate: | n/a |
26 | chr4:125638274-125638324 | HIPEpiC | eye: | n/a |
27 | chr4:125638274-125638324 | AG04449 | skin: | fetal |
28 | chr4:125638274-125638324 | AoSMC | blood vessel: | n/a |
29 | chr4:125638274-125638324 | ProgFib | skin: | n/a |
30 | chr4:125638274-125638324 | NT2-D1 | testis: | n/a |
31 | chr4:125638274-125638324 | NB4 | blood: | n/a |
32 | chr4:125638274-125638324 | SK-N-SH | brain: | n/a |
33 | chr4:125638274-125638324 | HAEpiC | amniotic membrane: | n/a |
34 | chr4:125638274-125638324 | NHBE | bronchial: | n/a |
35 | chr4:125638274-125638324 | BJ | skin: | n/a |
36 | chr4:125638274-125638324 | HRPEpiC | eye: | n/a |
37 | chr4:125638274-125638324 | HCF | heart: | n/a |
38 | chr4:125638274-125638324 | T-47D | breast: | n/a |
39 | chr4:125638274-125638324 | PFSK-1 | brain: | n/a |
40 | chr4:125638274-125638324 | HL-60 | blood: | n/a |
41 | chr4:125638274-125638324 | AG09309 | skin: | n/a |
42 | chr4:125638274-125638324 | Hela-S3 | cervix: | n/a |
43 | chr4:125638274-125638324 | HCPEpiC | choroid plexus: | n/a |
44 | chr4:125638274-125638324 | HPAEpiC | pulmonary alveolar: | n/a |
45 | chr4:125638274-125638324 | A549 | lung: | n/a |
46 | chr4:125638274-125638324 | BE2_C | brain: | n/a |
47 | chr4:125638274-125638324 | RPTEC | kidney: | n/a |
48 | chr4:125638274-125638324 | HRCEpiC | kidney: | n/a |
49 | chr4:125638274-125638324 | MCF-7 | breast: | n/a |
50 | chr4:125638274-125638324 | Hepatocyte | liver: | n/a |
(count:15 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:125632759..125636497-chr4:125636675..125640735,7 | K562 | blood: | |
2 | chr4:125644097..125646072-chr4:125648999..125650818,2 | MCF-7 | breast: | |
3 | chr4:125639869..125641790-chr4:125860741..125863223,2 | MCF-7 | breast: | |
4 | chr4:125644097..125646072-chr4:125648999..125650818,2 | MCF-7 | breast: | |
5 | chr4:125631965..125635401-chr4:125643572..125647788,6 | MCF-7 | breast: | |
6 | chr4:125634681..125637272-chr4:125648619..125650581,2 | MCF-7 | breast: | |
7 | chr4:125641922..125644236-chr4:125647065..125649623,2 | MCF-7 | breast: | |
8 | chr4:125635481..125637257-chr4:125647844..125649623,2 | K562 | blood: | |
9 | chr4:125631979..125634055-chr4:125640658..125642970,2 | MCF-7 | breast: | |
10 | chr4:125634057..125636507-chr4:125646321..125649119,3 | MCF-7 | breast: | |
11 | chr4:125633520..125636549-chr4:125645443..125647612,3 | K562 | blood: | |
12 | chr4:125638392..125640258-chr4:125657557..125660546,2 | MCF-7 | breast: | |
13 | chr4:125641922..125644236-chr4:125647065..125649623,2 | MCF-7 | breast: | |
14 | chr4:125642176..125644538-chr4:125687368..125689937,2 | MCF-7 | breast: | |
15 | chr4:125585555..125587922-chr4:125647750..125649339,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ANKRD50-7 | chr4:125644855-125645015 | ucscGeneNc_uc003ife_1 |
2 | lnc-ANKRD50-7 | chr4:125640547-125641599 | ucscGeneNc_uc003ife_1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ANKRD50 | TF binding region |
ANKRD50 | CpG island |
ENSG00000151458 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17008503 | chr4:125637940-125637941 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs548079338 | chr4:125637947-125637948 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs566386376 | chr4:125637966-125637967 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs190531854 | chr4:125637996-125637997 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs139071464 | chr4:125638013-125638014 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs114358230 | chr4:125638047-125638048 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs537987618 | chr4:125638063-125638064 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs182738780 | chr4:125638117-125638118 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs547777893 | chr4:125638123-125638124 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs7695971 | chr4:125638132-125638133 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs574937417 | chr4:125638148-125638149 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs9997688 | chr4:125638202-125638203 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs554522300 | chr4:125638271-125638272 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs149030979 | chr4:125638275-125638276 | Weak transcription Enhancers | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs145182294 | chr4:125638314-125638315 | Weak transcription Enhancers | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs187292246 | chr4:125638324-125638325 | Weak transcription Enhancers | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs376539904 | chr4:125638344-125638345 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs532122006 | chr4:125638408-125638409 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs544025989 | chr4:125638422-125638423 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs377515831 | chr4:125638441-125638442 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs562559771 | chr4:125638588-125638589 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs529860416 | chr4:125638608-125638609 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs547948913 | chr4:125638612-125638613 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs566453533 | chr4:125638648-125638649 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs72931241 | chr4:125638671-125638672 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs552037591 | chr4:125638675-125638676 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs570798526 | chr4:125638712-125638713 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs538192353 | chr4:125638765-125638766 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs556391045 | chr4:125638773-125638774 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs191695938 | chr4:125638822-125638823 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs80135458 | chr4:125638823-125638824 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs370756539 | chr4:125638865-125638866 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs539094954 | chr4:125638878-125638879 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs374812697 | chr4:125638879-125638880 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs146872370 | chr4:125638924-125638925 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs1874747 | chr4:125638980-125638981 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs573465738 | chr4:125639033-125639034 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs546558248 | chr4:125639046-125639047 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs140677356 | chr4:125639064-125639065 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs76921827 | chr4:125639074-125639075 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs544156717 | chr4:125639096-125639097 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs184658136 | chr4:125639106-125639107 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs529714483 | chr4:125639145-125639146 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs79265298 | chr4:125639149-125639150 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs541504436 | chr4:125639163-125639164 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs145764215 | chr4:125639164-125639165 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs527474256 | chr4:125639228-125639229 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs552236395 | chr4:125639247-125639248 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs148115251 | chr4:125639301-125639302 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs531623692 | chr4:125639315-125639316 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Developmental delay | 21147756 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:125634800-125639200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr4:125635000-125638000 | Weak transcription | Dnd41 | blood |
3 | chr4:125635000-125639800 | Weak transcription | HepG2 | liver |
4 | chr4:125635000-125644800 | Weak transcription | NHDF-Ad | bronchial |
5 | chr4:125635200-125638200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr4:125635200-125648000 | Weak transcription | HSMM | muscle |
7 | chr4:125638000-125639200 | Enhancers | Dnd41 | blood |
8 | chr4:125639200-125639600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr4:125639400-125640000 | Enhancers | K562 | blood |
10 | chr4:125639800-125640000 | Enhancers | HepG2 | liver |
11 | chr4:125643200-125643800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
12 | chr4:125643400-125643600 | Enhancers | HSMMtube | muscle |
13 | chr4:125643400-125643800 | Enhancers | Fetal Heart | heart |
14 | chr4:125643400-125645400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr4:125643600-125644400 | Weak transcription | HSMMtube | muscle |
16 | chr4:125644400-125645200 | Enhancers | HSMMtube | muscle |
17 | chr4:125644800-125645200 | Enhancers | NHDF-Ad | bronchial |
18 | chr4:125648600-125648800 | Enhancers | HSMM | muscle |